Introduction
Tonsillectomy is one of the most commonly performed operations in children in the US, with over half a million tonsillectomies performed in the US in children aged under 15 per year. 1 Tonsillectomies in children are associated with significant morbidity and rarely, mortality. Common complications following tonsillectomy include respiratory depression, inadequate pain control, hypovolemia secondary to decreased oral intake, and postoperative hemorrhage. 2 Tonsillectomy (with or without adenoidectomy) is associated with significant pain and postoperative pain control is often unsatisfactory, frequently persisting beyond the seventh postoperative day. Inadequate pain control may lead to decreased oral intake, readmission for pain control, and continued pathologic responses to pain may Ambulatory Anesthesia downloaded from https://www.dovepress.com/ by 54.70.40.11 on 14-Dec-2018 For personal use only. 
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Hansen et al lead to chronic pain in adulthood. 3 Opioid analgesics, while previously considered first-line therapy, may be associated with inadequate analgesia and side effects such as nausea, vomiting, pruritus, decreased gastrointestinal motility, sedation, and respiratory depression.
Up to 80% of tonsillectomies are performed for sleepdisordered breathing. 4 The population undergoing tonsillectomy is often young and presents with obstructive symptoms, potentially leading to hypoxic episodes postoperatively. This population has been shown to be particularly sensitive to the respiratory depressant effects of morphine. 5 Recent black-box warnings on codeine use due to variable pharmacodynamics have resulted in changes in standard of care and investigations into nonnarcotic and multimodal analgesic regimens. 6 Here we discuss the various strategies that have been investigated to more adequately and safely control pain following tonsillectomy.
Discussion
Codeine is a weak analgesic frequently used in children for the treatment of mild-to-moderate pain. 7 Morphine, the product of codeine metabolism via cytochrome P450 2D6 (CYP2D6) is the primary agent responsible for the analgesic effects of codeine. 7 The quantity of morphine produced from this reaction is highly variable and phenotype-dependent. Four phenotypes have been described: poor metabolizer (PM), intermediate metabolizer (IM), extensive metabolizer (EM), and ultrarapid metabolizer (UM). 7 While PM's produce very limited morphine and often experience inadequate pain relief, UM's produce increased amounts of morphine and are at risk of opioid intoxication. US Food and Drug Administration (FDA) reviewed data of adverse events in children from 1969 to May 2012 and found 13 cases of codeine-related adverse events, ten of which resulted in death. 8 The majority of these cases were following tonsillectomy and children ranged from 21 months to 9 years of age. Of the seven children undergoing genetic analysis, three were found to be ultrafast metabolizers and one probably ultrafast metabolizer. 8 In February 2013, the FDA declared that codeine is contraindicated for postoperative analgesia use in children.
Morphine is a frequently used analgesic for moderateto-severe pain in children. While widely used intravenously during the perioperative period, oral morphine for postoperative pain has poor bioavailability, a narrow therapeutic index and large interindividual variability in plasma levels following intake. 6 Morphine is metabolized into morphine-3-glucuronide and morphine-6-glucuronide. Morphine-6-glucuronide is an active metabolite that is more potent than morphine with both analgesic and respiratory depressant effects and may accumulate with repeated dosing. Oral morphine increased the risk of postoperative oxygen desaturation compared with ibuprofen in a recent study with no difference in analgesic effectiveness or posttonsillar hemorrhage rates. 9 Given the large individual variability, rates of oxygen desaturation and lack of improvement in pain control compared to ibuprofen, morphine is likely not an effective replacement for codeine.
Hydromorphone may offer an analgesic advantage over morphine, however, not an improved side effect profile with respect to nausea, vomiting, or itching. 10 However, studies specific to hydromorphone in comparison to morphine specifically for pediatric tonsillectomy are lacking. Hydromorphone is also associated with a high number of medication errors due to errors in conversion of equipotent doses from morphine. 6 Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective analgesics, however, their use is controversial following tonsillectomy given the concern for bleeding. Ketorolac (0.5 mg/kg max up to 30 mg intravenous [IV]) use in particular has been associated with postton sillar hemorrhage, with rates ranging from 4.4% to 18%. 11 A recent retrospective chart review revealed increased rates of posttonsillar hemorrhage requiring return to operating room in children who received ibuprofen plus acetaminophen (1.6%) versus narcotic plus acetaminophen (0.5%). 12 However, this is conflicting with a Cochrane review, with over 900 children from randomized control trials, which found that NSAIDs did not significantly alter postoperative bleeding compared with placebo or other pain management strategies. 11 IV ibuprofen given on induction has been shown to decrease dosage of rescue fentanyl in the recovery period with no significant difference in surgical blood loss or incidence of postoperative rebleeding. 13 As previously mentioned, oral ibuprofen (4-10 mg/kg) when combined with acetaminophen was associated with effective analgesia and less desaturation events on the first postoperative night than morphine combined with acetaminophen. 9 These findings demonstrate that NSAIDs, excluding ketorolac, can be used safely and effectively in the perioperative period and may have a narcotic-sparing effect. However, the decision to give an NSAID intraoperatively requires discussion with the surgical team involved, and surgeons may be hesitant to administer medications that can lead 
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Pediatric tonsillectomy pain to potential postoperative complications such as bleeding. In our practice, we typically do not administer ketorolac perioperatively for posttonsillectomy pain.
IV acetaminophen is indicated to treat mild-to-moderate postoperative pain in children. It has been shown to improve postoperative pain control as well as shorten post-anesthesia care unit (PACU) stay by ∼10 minutes. 14 A recent study demonstrated that the combination of IV acetaminophen and opioids are more effective in preventing need for rescue analgesia and more cost-effective. 4 Although the medication cost of IV acetaminophen is higher, the shortened postanesthesia recovery unit stay and decreased need for rescue analgesia was proven to be cost-effective. While useful in conjunction with opioids, acetaminophen alone may not provide adequate analgesia. 11 Postoperatively, scheduled dosing of acetaminophen with hydrocodone was found to be more effective than as needed dosing. 15 Perioperative use of dexamethasone has been shown to improve postoperative vomiting, improve pain control, and decreases airway swelling. 16 Dexamethasone decreases throat pain and improves time to consumption of oral intake. 11 Previous studies have raised concerns that steroids may interfere with postoperative hemostasis at concentrations of both 0.05 and 0.5 mg/kg. 17 However, more recent meta-analyses have found no overall objective increase in bleeding following tonsillectomy. 5 Dexamethasone remains a useful adjunct for both pain control and antiemetic effects.
Randomized clinical trials have shown no evidence that intraoperative injection of local anesthetics are effective in improving pain control. 11 A Cochrane review of perioperative local anesthetic injection showed no improvement in post operative pain, however, the authors noted the effects may be masked by coadministration of intravenous opioids. 18 More recent studies have found that peritonsillar dexamethasone infiltration was more effective than local anesthetic or saline in reducing postoperative pain. 19 Ketamine is a noncompetitive antagonist of N-methyl-Daspartate (NMDA) receptors and can exert analgesic effects. Ketamine has less effect on respiratory drive and airway patency than opioid analgesics. The limitations of ketamine include its psychomimetic effects such as hallucinations and depersonalization, although these effects are not typically seen at low doses. 20 A recent meta-analysis revealed decreased analgesic requirement in subjects who received ketamine preoperatively compared to control without adverse effects such as hallucinations. 20 The S (+) ketamine stereoisomer has been shown to have fewer side effects in patients, however, it has not been shown to improve pain control in children. This, however, has not yet been studied in tonsillectomies. Magnesium infusions have been shown to improve pain control following multiple adult surgeries, likely via an NMDA antagonist effect. However, a previous study on pediatric patients showed that an intraoperative magnesium infusion did not attenuate discomfort or emergence delirium following tonsillectomy. 21 A more recent study found that a magnesium bolus followed by infusion was effective in improving emergence delirium, potentially due to an analgesic effect. 22
Conclusion
Optimal pain control regimens following pediatric tonsillectomy continue to be a challenge for both anesthesiologists and otorhinolaryngologists. Opioids are associated with significant side effects, and this patient population remains at high risk for opioid-related postoperative respiratory depression. Despite this concern, complete opioid sparing techniques are not likely to provide adequate analgesia. Adjuncts such as IV ibuprofen, IV acetaminophen, dexame thasone, and NMDA antagonists may be safely used in the perioperative period and may have narcotic sparing effects as well as costeffectiveness. Further research into additional analgesics such as IV lidocaine and peritonsillar infiltration adjuncts may provide additional insight.
